Publikationsliste bei

Publikationsliste bei

Publikationsliste bei

 

Ausgewählte Publikationen

Meyer Zu Horste G, Wu C, Wang C, Cong L, Pawlak M, Lee Y, Elyaman W, Xiao S, Regev A, Kuchroo VK. RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression. Cell Rep. 2016 Jul 12;16(2):392-404.

Meyer Zu Horste G, Cordes S, Pfaff J, Mathys C, Mausberg AK, Bendszus M, Pham M, Hartung HP, Kieseier BC. Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis. PLoS One. 2016 Oct 6;11(10):e0164099.

Meyer zu Horste G, Derksen A, Stassart R, Szepanowski F, Thanos M, Stettner M, Boettcher C, Lehmann HC, Hartung HP, Kieseier BC (2015). Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System. J Neuropathol Exp Neurol. 2015 Nov;74(11):1077-85.

Meyer zu Hörste G, Cordes S, Mausberg AK, Zozulya AL, Wessig C, Sparwasser T, Mathys C, Wiendl H, Hartung HP,Kieseier BC (2014). FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies. PLoS One2014 9(10):e108756

Meyer zu Horste G, Mausberg AK, Cordes S, El-Haddad H, Partke HJ, Martin S, Roden M, Steinman L, Hartung HP, Kieseier BC. Thymic epithelium determines a spontaneous chronic neuritis in NODtm1Jcgr mice (2014). The Journal of Immunology 193(6):2678-90.

Mausberg AK, Dorok M, Stettner M, Müller M, Hartung HP, Dehmel T, Warnke C, Meyer Zu Hörste G*, Kieseier BC* (2013). Recovery of the T-cell repertoire in CIDP by IV immunoglobulins.Neurology 80(3):296-303. * equally contributing last authorship

Meyer zu Hörste G, Miesbach TA, Müller JI, Fledrich R, Stassart RM, Kieseier BC, Coleman MP, Sereda MW (2011). The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiol Dis42(1):1-8.

Meyer zu Hörste G, Heidenreich H, Mausberg AK, Lehmann HC, ten Asbroek AL, Saavedra JT, Baas F, Hartung HP, Wiendl H, Kieseier BC (2010). Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiol Dis37(2):483-90.

Meyer zu Horste G, Heidenreich H, Lehmann HC, Ferrone S, Hartung HP, Wiendl H, Kieseier BC (2010). Expression of antigen processing and presenting molecules in Schwann cells in inflammatory neuropathies. Glia58(1):80-92.

Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW (2007). Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol61(1): 61-72.

Sereda MW*, Meyer zu Hörste G*, Suter U, Uzma N, Nave KA (2003). Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 9(12): 1533-7. * equally contributing first authorship